Skip to main content
. Author manuscript; available in PMC: 2013 Oct 10.
Published in final edited form as: J Neurooncol. 2012 Feb 23;108(1):179–185. doi: 10.1007/s11060-012-0828-1

Table 1.

Patient and treatment characteristics

Patient,
sex, age
at GK		 Tumor
location		 TV
(cm3)		 Prescription
dose		 CI (treatment
volume/TV)		 Recurrence
type (in-field,
marginal, distant)		 Time to first
recurrence
after GK		 Prior
fractionated
radiation
(Y/N)
1, F, 68 Frontal lobe 6.6 12.5 Gy to 48% isodose line 1.68 Marginal 64 months N
2, M, 30 Frontal lobe 0.168 15 Gy to 50% isodose line 3.51 Marginal 20 months Y
3, F, 73 Frontal lobe 7 15 Gy to 50% isodose line 2.01 Distant 25 months Y
4, M, 78 Frontal lobe 11.3 13.5 Gy to 45% isodose line 1.72 In-field 2 months Y
5, F, 69 Frontal lobe 13.4 12 Gy to 45% isodose line 1.04 In-field 2 months Y
6, F, 63 Frontal lobe 1.8 18 Gy to 50% isodose line 1.56 In-field 94 months N
7, F, 51 Cavernous sinus 8.35 14 Gy to 50% isodose line 1.2 In-field 19 months N
8, M, 70 Frontal lobe 8.9 14 Gy to 50% isodose line 1.12 In-field 11 months N
9, F, 57 Frontal lobe 6.3 15 Gy to 50% isodose line 1.43 No recurrence N/A N
10, F, 55 Frontal lobe 0.32 12.5 Gy to 45% isodose line 16.5 No recurrence N/A N
11, F, 68 Temporal lobe 1.8 16 Gy to 50% isodose line 2.83 No recurrence N/A N
12, F, 57 Frontal lobe 25.4 10.5 Gy to 50% isodose line 1.39 In-field 5 months N
13, M, 63 Frontal lobe 0.629 18 Gy to 50% isodose line 2.38 Marginal 26 months Y
14, M, 74 Frontal lobe 44.08 11.5 Gy to 44% isodose line 1.91 No recurrence N/A N
15, F, 58 Frontal lobe 1.8 15 Gy to 47% isodose line 1.39 In-field 15 months Y
16, F, 58 Parietal lobe 0.23 17 Gy to 50% isodose line 12.85 In-field 12 months Y
17, F, 76 Cavernous sinus 4.7 12.7 Gy to 50% isodose line 1.38 In-field 12 months N
18, F, 83 Parietal lobe 0.32 12 Gy to 50% isodose line 1.84 No recurrence N/A Y
19, F, 67 Parietal lobe 23.3 12 Gy to 50% isodose line 1.46 No recurrence N/A N
20, F, 70 Temporal lobe 8 12 Gy to 50% isodose line 1.63 No recurrence N/A N
21, M, 66 Parietal lobe 1.8 18 Gy to 50% isodose line 1.56 No recurrence N/A N
22, F, 69 Parietal lobe Not available 14 Gy to 50% isodose line Not available Marginal 6 months Y
23, F, 58 Frontal lobe 6.2 16 Gy to 50% isodose line 1.65 No recurrence N/A Y
24, M, 6 Frontal lobe 0.21 18 Gy to 50% isodose line 2.78 No recurrence N/A N